CANADIAN CANCER TRIALS GROUP (CCTG) LY.17: A RANDOMIZED PHASE II STUDY EVALUATING NOVEL SALVAGE THERAPY PRE‐AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RR‐DLBCL) ‐ OUTCOME OF IBRUTINIB + R‐GDP. (June 2017) - Kuruvilla, J.; Crump, M.; Villa, D.; Aslam, M.; Prica, A.; Scott, D.W.; Abdel‐Samad, N.; Couban, S.; Doucet, S.; Dudebout, J.; Fleury, I.; Fraser, G.; et al.